SD

Swiss Diabetes Venture Fund

Europe, Vaud, Switzerland, Lausanne

Description

Swiss Diabetes Venture Fund is a europe’s first venture fund dedicated to diabetes technology.

Investor Profile

Swiss Diabetes Venture Fund has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 75% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland, Norway.
  • Strong thematic focus on Health Care, Medical Device, Medical.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United States (25%)
  • Switzerland (25%)
  • Norway (25%)
  • Sweden (25%)

Industry Focus

  • Health Care
  • Medical Device
  • Medical
  • Health Diagnostics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Swiss Diabetes Venture Fund frequently co-invest with?

NC
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Jolt Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Ambrosia Investments
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Alpha MOS
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Co-Investments: 1
BioSerenity
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Swiss Diabetes Venture Fund?

Luna Diabetes

San Diego, California, United States

Luna Diabetes is a manufacturer of medical equipment.

Health CareManufacturingMedical DevicePharmaceutical
Series AAug 18, 2025
Amount Raised: $23,621,230
BOYDSenseBOYDSense SAS

South San Francisco, California, United States

BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath.

Health CareHealth DiagnosticsMedical Device
Series UnknownApr 5, 2024
Amount Raised: $7,590,544
GlucoSet

Trondhjem, Sor-Trondelag, Norway

GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.

Health CareMedicalMedical Device
Series AJul 7, 2023
Amount Raised: $6,581,401
Piomic

Zürich, Zurich, Switzerland

Advanced wound care, made personal.

Health CareMedicalMedical DeviceTherapeutics
Series AJul 28, 2022
Amount Raised: $7,857,879
Digital Diabetes Analytics

Solna, Stockholms Lan, Sweden

Digital Diabetes Analytics radically fights diabetes with AI-based analysis of continuous glucose monitor (CGM) data.

Health CareMedicalMedical Device
Series UnknownJan 1, 2022

Find More Investors Like Swiss Diabetes Venture Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Swiss Diabetes Venture Fund | Pipeseed